CBS 2019
CBSMD教育中心
中 文

Acute Coronary Syndrom

Abstract

Recommended Article

Incidence, predictors, and outcomes of DAPT disruption due to non-compliance vs. bleeding after PCI: insights from the PARIS Registry Effect of a Restrictive vs Liberal Blood Transfusion Strategy on Major Cardiovascular Events Among Patients With Acute Myocardial Infarction and Anemia: The REALITY Randomized Clinical Trial High-Sensitivity Troponin and The Application of Risk Stratification Thresholds in Patients with Suspected Acute Coronary Syndrome Relationship between therapeutic effects on infarct size in acute myocardial infarction and therapeutic effects on 1-year outcomes: A patient-level analysis of randomized clinical trials Mortality and morbidity in acutely ill adults treated with liberal versus conservative oxygen therapy (IOTA): a systematic review and meta-analysis Cardiovascular Risk and Statin Eligibility of Young Adults After an MI: Partners YOUNG-MI Registry Optimum Blood Pressure in Patients With Shock After Acute Myocardial Infarction and Cardiac Arrest Impact of treatment delay on mortality in ST-segment elevation myocardial infarction (STEMI) patients presenting with and without haemodynamic instability: results from the German prospective, multicentre FITT-STEMI trial

Original Research2019 Apr 1. [Epub ahead of print]

JOURNAL:Circulation. Article Link

Catheter Ablation of Refractory Ventricular Fibrillation Storm After Myocardial Infarction: A Multicenter Study

Komatsu Y, Hocini M, Nogami A et al. Keywords: refractory ventricular fibrillation storm; post MI; catheter Ablation; survival; mortality

ABSTRACT


BACKGROUND - Ventricular fibrillation (VF) storm after myocardial infarction (MI) is a life-threatening condition that necessitates multiple defibrillations. Catheter ablation is a potentially effective treatment strategy for VF storm refractory to optimal medical treatment. However, its impact on patient survival has not been verified in a large population.


METHODS - We conducted a multicenter, retrospective observational study involving consecutive patients who underwent catheter ablation of post-MI refractory VF storm without preceding monomorphic ventricular tachycardia. The target of ablation was the Purkinje-related ventricular extrasystoles triggering VF. The primary outcome was in-hospital and long-term mortalities. Univariate logistic regression and Cox proportional-hazards analysis were used to evaluate clinical characteristics associated with in-hospital and long-term mortalities, respectively.


RESULTS - One-hundred ten patients were enrolled (65±11years; 92 men; left ventricular ejection fraction [LVEF] 31±10%). VF storm occurred at acute phase of MI (4.5±2.5 days after the MI onset during index hospitalization for MI) in 43 (39%) patients, subacute (>1 week) in 48 (44%), and remote (>6 months) in 19 (17%). The focal triggers were found to originate from the scar border zone in 88 (80%) patients. During in-hospital stay after ablation, VF storm subsided in 92 (84%) patients. Overall, 30 (27%) in-hospital deaths occurred. The duration from the VF occurrence to the ablation procedure was associated with in-hospital mortality (odds ratio for each one-day increase: 1.11; 95% confidence interval [CI]: 1.03-1.20; p=0.008). During follow-up after discharge from hospital, only one patient developed recurrent VF storm. However, 29 (36%) patients died with a median survival time of 2.2 years (interquartile range: 1.2-5.5 years). Long-term mortality was associated with LVEF<30% (hazard ratio [HR]: 2.54; 95%CI: 1.21-5.32; p=0.014), New York Heart Association class III (HR: 2.68; 95%CI: 1.16-6.19; p=0.021), a history of atrial fibrillation (HR: 3.89; 95%CI: 1.42-10.67; p=0.008), and chronic kidney disease (HR: 2.74; 95%CI: 1.15-6.49; p=0.023).


CONCLUSIONS - In patients with MI presenting with focally-triggered VF storm, catheter ablation of culprit triggers is life-saving and appears to be associated with short- and long-term freedom from recurrent VF storm. Mortality over long-term follow-up is associated with the severity of underlying cardiovascular disease and comorbidities in this specific patient population.